HOPX functions as a tumour suppressor in head and neck cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yap, Lee Fah ^a   Lai, Sook Ling ^a   Patmanathan, Sathya Narayanan ^a   Gokulan, Ravindran ^a   Robinson, C Max ^b   White, Joe B ^c   Chai, San Jiun ^d   Rajadurai, Pathmanathan ^e   Prepageran, Narayanan ^a   Liew, Yew Toong ^a   Lopes, Victor ^f   Wei, Wenbin ^g,h   Hollows, Robert J ^g   Murray, Paul G ^g   Lambert, Daniel W ^c   Hunter, Keith D ^c   Paterson, Ian C ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d CANCER RESEARCH MALAYSIA   (Malaysia)

^e SUBANG JAYA MEDICAL CENTRE   (Malaysia)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; HOP PROTEIN, HUMAN; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN;

DNA DAMAGE; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEAD AND NECK TUMOR; HOMEOSTASIS; HUMAN; PATHOLOGY; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA DAMAGE; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HOMEODOMAIN PROTEINS; HOMEOSTASIS; HUMANS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 85006021100     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38758     Document Type: Article

References (30)

1. Ang, K. K. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. The New England J. Med. 363, 24-35 (2010).
2. Zygogianni, A. G. et al. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 3, 2 (2011).
3. Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K. & Raab-Traub, N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. The New England J. Med. 333, 693-698 (1995).
4. Cancer Genome Atlas, N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 517, 576-582 (2015).
5. Chen, F. et al. Hop is an unusual homeobox gene that modulates cardiac development. Cell. 110, 713-723 (2002).
6. Kook, H. et al. Analysis of the structure and function of the transcriptional coregulator HOP. Biochemistry. 45, 10584-10590 (2006).
7. Shin, C. H. et al. Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell. 110, 725-735 (2002).
8. Ooki, A. et al. Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer. Oncogene. 29, 3263-3275 (2010).
9. Mariotto, A., Pavlova, O., Park, H. S., Huber, M. & Hohl, D. HOPX: The Unusual Homeodomain-Containing Protein. J. Invest. Dermatol. 136, 905-911 (2016).
10. Waraya, M. et al. Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis. BMC Cancer. 12, 397 (2012).
11. Yamashita, K. et al. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma. Mol. Cancer Res.: MCR. 6, 31-41 (2008).
12. Bose, S. et al. The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinoma. J. Pathol. 217, 345-352 (2009).
13. Hu, C. et al. A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels. PloS one. 7, e41055 (2012).
14. Hunter, K. D. et al. Divergent routes to oral cancer. Cancer Res. 66, 7405-7413 (2006).
15. Yap, L. F. et al. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrindependent Rac1 activation. Oncogene. 28, 2524-2534 (2009).
16. Sumino, J. et al. Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis. Int. J. Cancer. 132, 540-548 (2013).
17. Spencer, J. A. & Misra, R. P. Expression of the SRF gene occurs through a Ras/Sp/SRF-mediated-mechanism in response to serum growth signals. Oncogene. 18, 7319-7327 (1999).
18. Yap, L. F. et al. Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma. J. Pathol. 235, 456-465 (2015).
19. Lemaire, F. et al. Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma. Br. J. Cancer. 91, 258-261 (2004).
20. Chen, Y., Yang, L., Cui, T., Pacyna-Gengelbach, M. & Petersen, I. HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer. J. Pathol. 235, 397-407 (2015).
21. Katoh, H. et al. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer. Neoplasia. 14, 559-571 (2012).
22. Obarzanek-Fojt, M. et al. Homeodomain-only protein HOP is a novel modulator of late differentiation in keratinocytes. Eur. J. Cell Biol. 90, 279-290 (2011).
23. Cheung, W. K. et al. Control of alveolar differentiation by the lineage transcription factors GATA6 and HOPX inhibits lung adenocarcinoma metastasis. Cancer cell. 23, 725-738 (2013).
24. Chai, J., Baatar, D. & Tarnawski, A. Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology. 126, 1809-1818 (2004).
25. Yamaguchi, S., Asanoma, K., Takao, T., Kato, K. & Wake, N. Homeobox gene HOPX is epigenetically silenced in human uterine endometrial cancer and suppresses estrogen-stimulated proliferation of cancer cells by inhibiting serum response factor. Int. J. Cancer. 124, 2577-2588 (2009).
26. Edington, K. G., Loughran, O. P., Berry, I. J. & Parkinson, E. K. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss. Mol. Carcinogenesis. 13, 254-265 (1995).
27. McGregor, F. et al. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res. 62, 4757-4766 (2002).
28. McGregor, F. et al. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype. Cancer Res. 57, 3886-3889 (1997).
29. Prime, S. S. et al. The behaviour of human oral squamous cell carcinoma in cell culture. J. Pathol. 160, 259-269 (1990).
30. Detre, S., Saclani Jotti, G. & Dowsett, M. "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol. 48, 876-8 (1995).